Cannabidiol & Glucose Tolerance: Clinical Research Review
This article reviews cannabidiol glucose tolerance clinical trial findings in sedentary adults with overweight or obesity. The study found no significant improvements in glucose tolerance or gut microbiome with low-dose CBD. These findings highlight the…
Endocannabinoid System Clinical Research: CBD & Metabolic Health Insights
This pilot study examined cannabidiol glucose tolerance clinical trial evidence in sedentary adults with overweight or obesity. Results showed short-term low-dose CBD did not improve glucose tolerance or alter gut microbiome composition. These findings…
Endocannabinoid System Clinical Research: CBD & Metabolism Analysis
This cannabidiol glucose tolerance clinical research evaluates the impact of low-dose CBD supplementation on metabolic health. The study found no significant improvements in glucose tolerance or gut microbiome composition. These findings highlight the…